Cinchona Bark

Botanical Profile

Note on species delimitation: Historically and pharmacognostically, cinchona bark cannot be attributed exclusively to Cinchona officinalis. Pharmacopoeial and commercial references may include several Cinchona species and hybrids, especially C. pubescens, C. calisaya, C. ledgeriana and related forms. This profile should therefore be read in the broader commercial and pharmacognostic context of Cinchona.

Note on species delimitation: Historically and in commercial botany, cinchona bark has been associated with various Cinchona species.

Cinchona bark is historically derived from species of the genus Cinchona, particularly Cinchona officinalis and related species. The bark raw material is characterised by quinoline alkaloids such as quinine and quinidine and is of outstanding pharmacognostic importance.

Cinchona officinalis L. is a tree of the Rubiaceae family. The species originates from the South American Andes, particularly regions of Ecuador. Historically, however, bark from several Cinchona species and hybrids was traded under the name cinchona bark.

The dried bark is used. Botanically and in the history of trade, cinchona bark is a complex raw material because different Cinchona species can show different alkaloid profiles. Species and origin information are therefore central to pharmaceutical and historical classification.

Quality criteria include botanical identity, alkaloid content, bark age, origin, drying, purity and avoidance of confusion with other materials. In historical drug terminology, botanical species, pharmacopoeial drug and commercial material must be distinguished.

Botanically, cinchona bark represents one of the most pharmacognostically important bark drugs of the modern era.

Phytochemistry

The phytochemical profile of Cinchona barks is dominated by quinoline alkaloids. The principal compounds include quinine, quinidine, cinchonine and cinchonidine. Tannins, bitter substances, resins and other accompanying phenolic constituents are also present.

Alkaloid composition varies according to species, origin, bark age and processing. Historically, alkaloid content and bark quality were decisive quality characteristics.

Analytically, alkaloid determination, identity testing and purity parameters are central. Quinine and related alkaloids are pharmacologically highly relevant substances and clearly distinguish cinchona bark from ordinary bitter barks.

Phytochemically, cinchona bark is an alkaloid-rich bark drug with a distinct pharmaceutical history.

Traditional Uses

Cinchona bark has exceptional historical significance. Used in the South American Andes, it reached Europe in the early modern period and became one of the most important herbal drugs in European medical history.

Its traditional and historical use is closely linked with bitter barks, colonial plant trade, pharmacy practice and the development of alkaloid chemistry. Quinine was isolated from cinchona bark and became a landmark substance in the history of pharmacology.

This historical context should be clearly separated from modern legal product categories. Cinchona bark is not an ordinary herbal-tea raw material, but a pharmacognostically and regulatorily sensitive alkaloid drug.

For public-facing profiles, its special importance in the history of pharmacy, botany and alkaloid research should be emphasised.

Current Research

Current research on Cinchona species covers alkaloid biosynthesis, historical pharmacognosy, taxonomy, genetic resources, cultivation and quality analysis. Quinine and quinidine remain important reference substances in pharmaceutical and analytical work.

Historical research examines the role of cinchona bark in the medicinal-plant trade, colonial supply chains and the emergence of modern active-substance isolation. Botanical studies address species delimitation and Cinchona diversity.

Analytically, alkaloid profiles, chromatographic methods and differentiation of bark origins are central. This research is also relevant to the authenticity of historical drug samples.

Scientifically, cinchona bark should be presented as a classic alkaloid-rich pharmaceutical raw material with particular regulatory sensitivity.

Sources

• Plants of the World Online. Kew Science. Royal Botanic Gardens, Kew: Cinchona officinalis L.
• European Pharmacopoeia: Cinchonae cortex.
• Hager's Encyclopedia of Drugs and Medicinal Substances: Cinchona.
• PubMed literature on Cinchona alkaloids, quinine and quinidine.
• Pharmacognostic literature on bark drugs and alkaloid analysis.